FAQ

TJ-M2010-5

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2016
012319852016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice.
INTRODUCTION AND AIMS Studies have reported that myeloid differentiation factor 88 (MyD88) plays an important role in the… (More)
Is this relevant?
2016
2016
Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.
BACKGROUND The TLR/MyD88 signaling pathway is an important driver of inflammation and cancer and is a possible target for… (More)
Is this relevant?
2016
2016
Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro
The activation of innate immunity via myeloid differentiation factor 88 (MyD88) contributes to ischemia reperfusion (I/R) induced… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Dendritic cells play an essential role in transplantation responses via myeloid differentiation factor 88 signaling.
BACKGROUND DCs (dendritic cells), play an important role in allo-recognition, but there is no direct evidence that DCs trigger… (More)
Is this relevant?
2011
2011
Claim for patient fall after delivery was a medical malpractice claim. Martins v. Williamson Medical Center, No. M2010-00258-COA-R3-CV (Tenn. Ct. App. November 22, 2010).
  • John C West
  • Journal of healthcare risk management : the…
  • 2011
 
Is this relevant?
1985
1985
Bioluminescence screening for bacteriuria.
A rapid screening test (45 min) for bacteriuria was evaluated in 1,000 clinical urine specimens. The test procedure is based upon… (More)
Is this relevant?